AIP
LENZ

Ameritas Investment Partners’s LENZ Therapeutics LENZ Stock Holding History

Ameritas Investment Partners’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4K Hold
1,351
– – ﹤0.01% 2797
2025
Q4 		$21.6K Hold
1,351
– – ﹤0.01% 2606
2025
Q3 		$62.9K Sell
1,351
-466
-26% -$17.1K ﹤0.01% 1971
2025
Q2 		$53.3K Buy
1,817
+586
+48% +$15.9K ﹤0.01% 2148
2025
Q1 		$31.6K Hold
1,231
– – ﹤0.01% 2355
2024
Q4 		$35.5K Hold
1,231
– – ﹤0.01% 2381
2024
Q3 		$29.2K Hold
1,231
– – ﹤0.01% 2470
2024
Q2 		$21.3K Buy
1,231
+900
+272% +$15.7K ﹤0.01% 2584
2024
Q1 		$7.38K Hold
331
– – ﹤0.01% 2890
2023
Q4 		$6.06K Hold
331
– – ﹤0.01% 2941
2023
Q3 		$5.74K Hold
331
– – ﹤0.01% 2967
2023
Q2 		$6.02K Buy
+331
New +$6.61K ﹤0.01% 3001
2022
Q2 		– Sell
-178
Closed -$6K – 3259
2022
Q1 		$6K Hold
178
– – ﹤0.01% 2947
2021
Q4 		$15K Hold
178
– – ﹤0.01% 2770
2021
Q3 		$20K Buy
+178
New +$26.4K ﹤0.01% 2712

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Ameritas Investment Partners's LENZ Position: Q1 2026 in Review

Ameritas Investment Partners held its LENZ Therapeutics (LENZ) position steady in Q1 2026 at 1,351 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2797.

Ameritas Investment Partners first reported a position in LENZ in Q3 2021 and has held it in 15 quarters since. The position peaked at $62.9K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Ameritas Investment Partners held 1,351 shares of LENZ Therapeutics worth $12.4K as of Q1 2026.
  • Ameritas Investment Partners left its LENZ Therapeutics share count unchanged in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2797 holding.
  • Ameritas Investment Partners first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 15 quarters since.
  • Ameritas Investment Partners's LENZ Therapeutics position peaked at $62.9K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.